UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	September 18, 2018

Accession Number:	0001193125-18-265133
Submission Type:	POS AM
CIK: 0001422142 Company Name: Aerpio Pharmaceuticals, Inc. File Number: 333-217320